Cargando…

Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy

Preeclampsia (PE) is characterized by new onset hypertension in association with placental ischemia, reduced fetal weight, elevated soluble fms-like tyrosine kinase-1 (sFlt-1), and placental mitochondrial (mt) dysfunction and oxidative stress (ROS). Progesterone induced blocking factor (PIBF) is a p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deer, Evangeline, Jones, Jalisa, Cornelius, Denise C., Comley, Kyleigh, Herrock, Owen, Campbell, Nathan, Fitzgerald, Sarah, Ibrahim, Tarek, LaMarca, Babbette, Amaral, Lorena M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616090/ https://www.ncbi.nlm.nih.gov/pubmed/34831040 http://dx.doi.org/10.3390/cells10112817

Ejemplares similares

Low Dose of IL-2 Normalizes Hypertension and Mitochondrial Function in the RUPP Rat Model of Placental Ischemia
por: Deer, Evangeline, et al.
Publicado: (2021)

17-Hydroxyprogesterone caproate improves hypertension and renal endothelin-1 in response to sFlt-1 induced hypertension in pregnant rats
por: Amaral, Lorena M., et al.
Publicado: (2020)

Setting a stage: Inflammation during preeclampsia and postpartum
por: Herrock, Owen, et al.
Publicado: (2023)

CD4+ T-Cells cause cognitive dysfunction in preeclampsia or COVID-19 infection in a pregnant rat model
por: Sullivan, Kimberly S., et al.
Publicado: (2023)

Is Mitochondrial Oxidative Stress a Viable Therapeutic Target in Preeclampsia?
por: Vaka, Ramana, et al.
Publicado: (2022)

Characterization of Mitochondrial Bioenergetics in Preeclampsia
por: Vaka, Ramana, et al.
Publicado: (2021)

Preeclampsia: long-term consequences for vascular health
por: Amaral, Lorena M, et al.
Publicado: (2015)

RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
por: Turanov, Anton A., et al.
Publicado: (2018)

Investigation of interleukin-2-mediated changes in blood pressure, fetal growth restriction, and innate immune activation in normal pregnant rats and in a preclinical rat model of preeclampsia
por: Cunningham, Mark W., et al.
Publicado: (2021)

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
por: Moore, Kyle H., et al.
Publicado: (2020)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
por: Li, Lei, et al.
Publicado: (2020)

Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
por: Nuzzo, Anna Maria, et al.
Publicado: (2021)

Chemical optimization of siRNA for safe and efficient silencing of placental sFLT1
por: Davis, Sarah M., et al.
Publicado: (2022)

Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy
por: Gurnadi, Jeffry Iman, et al.
Publicado: (2015)

sFlt-1 Levels as a Predicting Tool in Placental Dysfunction Complications in Multiple Pregnancies
por: Giardini, Valentina, et al.
Publicado: (2023)

Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia
por: Charnock-Jones, D. Stephen
Publicado: (2016)

Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration
por: Herraiz, Ignacio, et al.
Publicado: (2015)

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
por: Sapantzoglou, Ioakeim, et al.
Publicado: (2023)

Human sFLT1 Leads to Severe Changes in Placental Differentiation and Vascularization in a Transgenic hsFLT1/rtTA FGR Mouse Model
por: Vogtmann, Rebekka, et al.
Publicado: (2019)

sFlt-1 in Chronic Kidney Disease: Friend or Foe?
por: Matsui, Masaru, et al.
Publicado: (2022)

Differential regulation of sFlt-1 splicing by U2AF65 and JMJD6 in placental-derived and endothelial cells
por: Eddy, Adrian C., et al.
Publicado: (2020)

VEGF and sFLT-1 in serum of PIH patients and effects on the foetus
por: Tang, Yanhong, et al.
Publicado: (2019)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
por: Tataru-Copos, Anca-Florina, et al.
Publicado: (2022)

Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1
por: Tanaka, Hiroaki, et al.
Publicado: (2022)

Full-Length Human Placental sFlt-1-e15a Isoform Induces Distinct Maternal Phenotypes of Preeclampsia in Mice
por: Szalai, Gabor, et al.
Publicado: (2015)

Prediction of Adverse Pregnancy Outcome Related to Placental Dysfunction Using the sFlt-1/PlGF Ratio: A Narrative Review
por: Graupner, Oliver, et al.
Publicado: (2021)

Reduced expression in preterm birth of sFLT-1 and PlGF with a high sFLT-1/PlGF ratio in extracellular vesicles suggests a potential biomarker
por: Hussein, Sama, et al.
Publicado: (2022)

Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice
por: Ku, Ching-Hsin, et al.
Publicado: (2008)

sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In Vivo
por: Altiok, Eda I., et al.
Publicado: (2016)

A simple detection method for the serum sFLT1 protein in preeclampsia
por: Shibuya, Masabumi, et al.
Publicado: (2021)

Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa
por: Wang, Na, et al.
Publicado: (2021)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population
por: Kumar, Namrata, et al.
Publicado: (2023)

MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia
por: Yong, Qing, et al.
Publicado: (2023)

Heme Oxygenase-1 Attenuates Hypoxia-Induced sFlt-1 and Oxidative Stress in Placental Villi through Its Metabolic Products CO and Bilirubin
por: George, Eric M., et al.
Publicado: (2012)

Attenuation of VEGFR-2 Expression by sFlt-1 and Low Oxygen in Human Placenta
por: Nevo, Ori, et al.
Publicado: (2013)

Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia
por: Souders, Colby A., et al.
Publicado: (2015)

In Vivo Experiments Reveal the Good, the Bad and the Ugly Faces of sFlt-1 in Pregnancy
por: Szalai, Gabor, et al.
Publicado: (2014)

Neuronal sFlt1 and Vegfaa determine venous sprouting and spinal cord vascularization
por: Wild, Raphael, et al.
Publicado: (2017)

Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1
por: Eslani, Medi, et al.
Publicado: (2017)

The Soluble VEGF Receptor sFlt-1 Contributes to Impaired Neovascularization in Aged Mice
por: Zhao, Guangxian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b26fcjmmdj6pph8q5ftl6pa45d